Bill Anderson is the CEO of Roche Pharmaceuticals. He serves as a member of Roche’s Executive Committee, overseeing the Pharmaceutical division. Leading an organisation of 55,000 people, he is passionate about helping people make meaningful progress every day on the things that matter to patients. With a world-leading investment in research and development, his vision is to bring more medical advances to patients at less cost to society.

His tenure at Roche has seen him serve as the CEO of Genentech, the Head of Global Product Strategy and in roles leading the US Oncology and Immunology business units. Mr. Anderson has a bachelor’s degree in chemical engineering from the University of Texas and earned masters degrees in management and chemical engineering from the Massachusetts Institute of Technology.